In this study, we utilised a novel KDM4 inhibitor based on the structure of IOX-1, the most characterised inhibitor of the 2-oxygenase enzymes to which the KDM4 family belong, to investigate further the role of KDM4A in AML. The gene discussed is KDM4A; the disease is acute myeloid leukemia.